Mid-Market Commentary
DSIJ Intelligence / 18 Oct 2016
The Indian markets carried on with their northward journey in the mid-session too. At present Nifty is trading up by 96 points to trade at 8616 and the Sensex is up by 337 points and is trading at 27866. Both the indices were seen trading higher by more than 1.5% each.
The Indian markets carried on with their northward journey in the mid-session too. At present Nifty is trading up by 96 points to trade at 8616 and the Sensex is up by 337 points and is trading at 27866. Both the indices were seen trading higher by more than 1.5% each.
On the NSE, the advance-decline ratio is positive with 1832 advances and 815 declines.
Marksans Pharma: Marksans Pharma has announced USFDA approval for Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg.
Accelya Kale Solutions: Accelya Kale Solutions' Connect2ERP achieves certified integration with SAP ERP running on SAP HANA.
V2 Retail: V2 Retail opens one operational Retail store of company at Sitamarhi, Bihar.
Shriram EPC: Shriram EPC bagged Rs 61 crore order from the Karnataka Water Authority.
Aarti Drugs: Aarti Drugs fixes record date for buyback of equity shares on November 1.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.